Third International Symposium on Cyclic Vomiting syndrome and Cannabinoid Hyperemesis Syndrome
第三届周期性呕吐综合征和大麻素剧吐综合征国际研讨会
基本信息
- 批准号:10609378
- 负责人:
- 金额:$ 1.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-15 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAccountingAddressAffectAmbulatory CareApplications GrantsAreaBasic ScienceBiologicalCannabinoidsCannabisCaregiversCeliac DiseaseChildhoodChronicChronic DiseaseClinicalClinical SciencesClinical TreatmentCollaborationsDevelopmentDigestive System DisordersDisciplineDiseaseEmergency department visitExpenditureFacultyFosteringFrequenciesFunctional disorderFundingFutureGastroenterologyGoalsGrowthHealthHealth PersonnelHealthcareHealthcare SystemsHospitalizationIndividualInflammatory Bowel DiseasesInternationalJournalsKnowledgeLeadLearningMentorshipMethodologyMigraineMinority GroupsModalityNational Institute of Diabetes and Digestive and Kidney DiseasesNatureNausea and VomitingNeurologistNeurologyNeurosciencesNursesOhioOutcomePatient Outcomes AssessmentsPatient-Focused OutcomesPatientsPeer ReviewPeriodicityPhysiciansPrevalencePublic HealthPublishingRegulationResearchResearch PersonnelResearch PriorityResourcesScienceScientistSyndromeTimeTranslational ResearchUnderrepresented MinorityUniversitiesVisitVomitingWomanWorkantagonistbasecare burdencareercell motilitycostdiversity and inclusiongut-brain axishealth care service utilizationimprovedmarijuana legalizationmarijuana usemeetingsneuroregulationnext generationnovel strategiesnovel therapeuticspostersprogramssymposiumtargeted treatmenttheories
项目摘要
Project summary
Cyclic vomiting syndrome (CVS) is a common chronic disorder of gut-brain interaction (DGBI) and has a
significant negative impact on patients, caregivers, and the health care system. Cannabinoid hyperemesis
syndrome (CHS) has a similar clinical presentation to CVS but is thought to be due to heavy cannabis use and
is being recognized with increasing frequency. How cannabis affects GI health is unclear and this is particularly
important to understand given the rapid legalization of cannabis that has outpaced both funding and research.
Despite CVS and CHS being important public health problems, there are significant knowledge gaps in part
due to a lack of meetings that focus on this area which can foster collaboration between disciplines and
accelerate research. Our current R13 grant application is a request to support a comprehensive scientific
symposium, the Third International Symposium on Cyclic Vomiting Syndrome and Cannabinoid
Hyperemesis Syndrome to be held at The Ohio State University in Columbus, Ohio on Nov 4-5, 2022. This
will contribute to the overall goal of the NIDDK to foster collaborative research and mentorship opportunities,
disseminate science-based information on digestive diseases and promote diversity and inclusion. The main
objectives of our conference are 1. Provide an interdisciplinary exchange forum to advance research on
biological mechanisms and clinical treatment of these interrelated disorders, CVS and CHS. 2. Foster
interaction between early-stage investigators/trainees and senior investigators in basic and clinical and
translational sciences to better understand mechanisms of nausea and vomiting 3. Provide a forum for health
care providers and researchers to learn about various treatment approaches and novel strategies to manage
CVS and CHS. 4. Promote inclusion with a particular emphasis on advancing the participation of women and
individuals from underrepresented minority (URM) groups which will foster their professional development 5.
Identify knowledge gaps, discuss methodological outcomes criteria for trials, and priorities for future research.
Speakers will present cutting edge research on nausea and vomiting related to cyclic vomiting, cannabis use
and cannabinoid hyperemesis, and migraine and discuss new modalities of therapy including neuromodulation,
and CGRP antagonists in the treatment of these disorders. A scientific poster session will be held where junior
investigators and trainees can present their work. The proceedings of the conference will be published in a
peer-reviewed journal: Neurogastroenterology and Motility. Conference attendees will include scientists
(neuroscience, gastroenterology, neurology), physicians (gastroenterology, neurologists, and geneticists), and
other healthcare providers (nurses, advanced practitioners). Inclusion of URM, and early-stage investigator
faculty will be a priority to facilitate the growth of the next generation of researchers.
项目摘要
周期性呕吐综合征(CVS)是一种常见的慢性肠-脑相互作用(DGBI)疾病,
对患者、护理人员和医疗保健系统产生重大负面影响。大麻素样呕吐
综合征(CHS)的临床表现与CVS相似,但被认为是由于大量使用大麻,
被越来越多地认识到。大麻如何影响GI健康尚不清楚,这尤其是
考虑到大麻的快速合法化已经超过了资金和研究,理解这一点很重要。
尽管CVS和CHS是重要的公共卫生问题,但在某些方面存在着重大的知识差距。
由于缺乏关注这一领域的会议,这一领域可以促进学科之间的合作,
加快研究。我们目前的R13赠款申请是一个请求,以支持一个全面的科学
第三届周期性呕吐综合征和大麻素国际研讨会
剧吐综合征将于2022年11月4日至5日在俄亥俄州哥伦布市的俄亥俄州立大学举行。这
将有助于NIDDK的总体目标,以促进合作研究和指导机会,
传播有关消化系统疾病的科学信息,促进多样性和包容性。主要
我们会议的目标是1.提供一个跨学科的交流论坛,以促进对
这些相互关联的疾病,CVS和CHS的生物学机制和临床治疗。2.福斯特
早期研究者/受训者与基础和临床领域高级研究者之间的互动,
转化科学,以更好地了解恶心和呕吐的机制3。提供健康论坛
护理提供者和研究人员了解各种治疗方法和新的战略,以管理
CVS和CHS。4.促进包容,特别强调促进妇女的参与,
来自代表性不足的少数群体的个人,这将促进他们的专业发展5。
确定知识差距,讨论试验的方法学结果标准,以及未来研究的优先事项。
演讲者将介绍与周期性呕吐,大麻使用有关的恶心和呕吐的前沿研究
大麻素性呕吐,偏头痛,并讨论新的治疗方法,包括神经调节,
和CGRP拮抗剂在治疗这些疾病中的应用。将举行一次科学海报会议,
调查员和受训人员可以介绍他们的工作。会议记录将在
同行评审期刊:Neurogastroenterology and Motility与会者将包括科学家
(神经科学,胃肠病学,神经病学),医生(胃肠病学,神经学家和遗传学家),以及
其他医疗保健提供者(护士,高级从业人员)。纳入URM和早期研究者
教师将是促进下一代研究人员成长的优先事项。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thangam Venkatesan其他文献
Thangam Venkatesan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 1.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 1.2万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 1.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 1.2万 - 项目类别:
Standard Grant
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 1.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 1.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 1.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 1.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 1.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 1.2万 - 项目类别: